Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S PESONEN

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Hereditas|October 29, 2010
Abortive egg cells in the mouseS PESONEN
BJOG : an International Journal of Obstetrics and Gynaecology|November 26, 2013
Commentary on 'Mobility impairment is associated with urge but not stress urinary incontinence in community-dwelling older women: results from the "Ossebo" study'J S Pesonen, K A O Tikkinen
The Journal of Urology|September 4, 2020
Editorial CommentJori S Pesonen, Kari A O Tikkinen
Steroidologia|January 1, 1970
Ultrastructural differentiation and progesterone- 14 C metabolism in cultured cells of fetal rat adrenals under influence of ACTHA I Kahri, S Pesonen, A Saure
Scandinavian Journal of Plastic and Reconstructive Surgery|January 1, 1976
On the [4-14C]progesterone metabolism of keloid and hypertrophic scar. A preliminary reportS Pesonen, A Rintala, A Soivio, et al.
Journal of Mental Deficiency Research|March 1, 1970
Aetiological aspects of the cutis verticis gyrata and mental retardation syndromeJ Palo, M Iivanainen, K Blomqvist, et al.
The Journal of Biological Chemistry|September 14, 2000
Membrane binding mechanism of an RNA virus-capping enzymeA Lampio, I Kilpeläinen, S Pesonen, et al.
Acta Veterinaria Scandinavica|November 13, 2004
Antimicrobial resistance in Staphylococcus spp., Escherichia coli and Enterococcus spp. in dogs given antibiotics for chronic dermatological disorders, compared with non-treated control dogsM Rantala, E Lahti, J Kuhalampil, et al.
Gene Therapy|April 11, 2008
Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodiesM Särkioja, S Pesonen, M Raki, et al.
Gene Therapy|May 15, 2009
Ad5/3-9HIF-Delta24-VEGFR-1-Ig, an infectivity enhanced, dual-targeted and antiangiogenic oncolytic adenovirus for kidney cancer treatmentK Guse, I Diaconu, M Rajecki, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Hereditas|October 29, 2010
Abortive egg cells in the mouseS PESONEN
BJOG : an International Journal of Obstetrics and Gynaecology|November 26, 2013
Commentary on 'Mobility impairment is associated with urge but not stress urinary incontinence in community-dwelling older women: results from the "Ossebo" study'J S Pesonen, K A O Tikkinen
The Journal of Urology|September 4, 2020
Editorial CommentJori S Pesonen, Kari A O Tikkinen
Steroidologia|January 1, 1970
Ultrastructural differentiation and progesterone- 14 C metabolism in cultured cells of fetal rat adrenals under influence of ACTHA I Kahri, S Pesonen, A Saure
Scandinavian Journal of Plastic and Reconstructive Surgery|January 1, 1976
On the [4-14C]progesterone metabolism of keloid and hypertrophic scar. A preliminary reportS Pesonen, A Rintala, A Soivio, et al.
Journal of Mental Deficiency Research|March 1, 1970
Aetiological aspects of the cutis verticis gyrata and mental retardation syndromeJ Palo, M Iivanainen, K Blomqvist, et al.
The Journal of Biological Chemistry|September 14, 2000
Membrane binding mechanism of an RNA virus-capping enzymeA Lampio, I Kilpeläinen, S Pesonen, et al.
Acta Veterinaria Scandinavica|November 13, 2004
Antimicrobial resistance in Staphylococcus spp., Escherichia coli and Enterococcus spp. in dogs given antibiotics for chronic dermatological disorders, compared with non-treated control dogsM Rantala, E Lahti, J Kuhalampil, et al.
Gene Therapy|April 11, 2008
Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodiesM Särkioja, S Pesonen, M Raki, et al.
Gene Therapy|May 15, 2009
Ad5/3-9HIF-Delta24-VEGFR-1-Ig, an infectivity enhanced, dual-targeted and antiangiogenic oncolytic adenovirus for kidney cancer treatmentK Guse, I Diaconu, M Rajecki, et al.
Pageof 3